ADC Therapeutics SA: how funds voted at the meeting of 3 Jun 2025
- Ticker
- ADCT
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 118
- Ballot items
- 7
118 filers on Form N-PX reported votes at the ADC Therapeutics SA meeting of 3 Jun 2025. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of ADC Therapeutics SA has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
12 nominees. 89.3% of the reported votes are for. 28 filers withheld from or voted against at least one nominee.
838 vote records from 41 filers. 0 of the 40 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 22 fund families
- For 21
- Split or no vote 1
Item 2: Advisory vote on executive pay (say-on-pay)
196 vote records from 118 filers. 7 of the 112 filers that marked the item voted against management. 6 filers gave no management mark.
- Positions of 29 fund families
- For 29
Item 3: Audit-related items (auditor ratification)
73 vote records from 41 filers. 0 of the 40 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 22 fund families
- For 22
Item 4: CAPITAL STRUCTURE: management items
The company's items in this category are shown together, because filers word and number them differently.
132 vote records from 40 filers. 4 of the 39 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 22 fund families
- For 4
- Against 1
- Split or no vote 17
- Against management 1
Item 5: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
353 vote records from 41 filers. 0 of the 40 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 22 fund families
- For 19
- Split or no vote 3
Item 6: CORPORATE GOVERNANCE: management items
The company's items in this category are shown together, because filers word and number them differently.
319 vote records from 41 filers. 0 of the 40 filers that marked the item voted against management. 1 filer gave no management mark.
- Positions of 22 fund families
- For 22
Item 7: OTHER: management items
The company's items in this category are shown together, because filers word and number them differently.
6 vote records from 3 filers. 0 of the 3 filers that marked the item voted against management.
- Positions of one fund family
- For 1
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Auditor |
|---|---|---|
| AllianceBernstein | For | No report |
| BlackRock and iShares | For | For |
| BNY Mellon | For | No report |
| Brighthouse Funds | For | For |
| Charles Schwab | For | For |
| Columbia Threadneedle | For | For |
| DWS | For | For |
| Equitable | For | For |
| Fidelity | For | For |
| Global X | For | For |
| Goldman Sachs | For | For |
| Guggenheim and Rydex | For | For |
| Invesco | For | No report |
| J.P. Morgan | For | No report |
| John Hancock and Manulife | For | For |
| Lincoln Financial | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Nationwide | For | For |
| Northern Trust and FlexShares | For | For |
| Nuveen and TIAA | For | For |
| Pacific Life funds | For | For |
| PGIM and Prudential | For | No report |
| Principal | For | No report |
| ProShares and ProFunds | For | For |
| Russell Investments | For | No report |
| State Street and SPDR | For | For |
| T. Rowe Price | For | For |
| Vanguard | For | For |
| Voya | For | For |
Questions
- How many filers reported votes at the ADC Therapeutics SA meeting?
- 118 Form N-PX filers reported votes at the meeting of 3 Jun 2025. On say-on-pay, 7 of 112 filers that marked the item voted against management (6.3%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. ADC Therapeutics SA reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list ADC Therapeutics SA with a meeting date within three days of 3 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .